Literature DB >> 11561030

Normal complement of motor units in asymptomatic familial (SOD1 mutation) amyotrophic lateral sclerosis carriers.

A Aggarwal1, G Nicholson.   

Abstract

OBJECTIVE: To understand the mechanisms causing neuronal death in amyotrophic lateral sclerosis (ALS), an electrophysiological technique of motor unit number estimation (MUNE) was used to examine the pattern of motor neuron loss in amyotrophic lateral sclerosis. The aim was to determine whether gradual lifelong loss of motor units precedes clinical disease or whether sudden, catastrophic loss of motor units occurs at the onset of the disease.
METHOD: Using the statistical technique of motor unit number estimation, a cross sectional study was performed on a group of asymptomatic carriers of the Cu, Zn superoxide dimutase 1 (SOD1) gene. MUNE results were compared with those from age and sex matched family controls who did not carry the SOD1 mutation. A total of 87 subjects (45 men and 42 women) with an age range from 16-73 years of age were studied.
RESULTS: There was no detectable difference in the number of motor units in SOD1 mutation carriers compared with SOD1 negative family controls or population controls. Symptomatic subjects showed a definite loss of motor units. The test-retest reproducibility of this technique yielded an average difference between MUNE results on separate occasions on the same subject of +/-5%.
CONCLUSION: The finding that presymptomatic SOD1 mutation carriers have a full complement of motor neurons indicates that mutation carriers must have normal survival of motor neurons until rapid and widespread cell death of these neurons occurs, coinciding with the onset of clinical features. This implies that symptomatic ALS is not the end result of a slow attrition of motor neurons.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561030      PMCID: PMC1763514          DOI: 10.1136/jnnp.71.4.478

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  Statistical motor unit number estimation: reproducibility and sources of error in patients with amyotrophic lateral sclerosis.

Authors:  R K Olney; E C Yuen; J W Engstrom
Journal:  Muscle Nerve       Date:  2000-02       Impact factor: 3.217

2.  Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis.

Authors:  M Azzouz; N Leclerc; M Gurney; J M Warter; P Poindron; J Borg
Journal:  Muscle Nerve       Date:  1997-01       Impact factor: 3.217

3.  A longitudinal study comparing thenar motor unit number estimates to other quantitative tests in patients with amyotrophic lateral sclerosis.

Authors:  K J Felice
Journal:  Muscle Nerve       Date:  1997-02       Impact factor: 3.217

Review 4.  Genetics of amyotrophic lateral sclerosis.

Authors:  T Siddique; H X Deng
Journal:  Hum Mol Genet       Date:  1996       Impact factor: 6.150

5.  Motor unit estimations in small muscles of the hand.

Authors:  R E Sica; A J McComas; A R Upton; D Longmire
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-01       Impact factor: 10.154

6.  Physiological changes in ageing muscles.

Authors:  M J Campbell; A J McComas; F Petito
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-04       Impact factor: 10.154

7.  Estimating the number of motor units in a muscle.

Authors:  J R Daube
Journal:  J Clin Neurophysiol       Date:  1995-11       Impact factor: 2.177

8.  Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia.

Authors:  P M Andersen; P Nilsson; M L Keränen; L Forsgren; J Hägglund; M Karlsborg; L O Ronnevi; O Gredal; S L Marklund
Journal:  Brain       Date:  1997-10       Impact factor: 13.501

9.  Functional compensation in partially denervated muscles.

Authors:  A J McComas; R E Sica; M J Campbell; A R Upton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-08       Impact factor: 10.154

10.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

View more
  8 in total

Review 1.  Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability?

Authors:  Kevin Talbot
Journal:  J Anat       Date:  2013-09-08       Impact factor: 2.610

Review 2.  Presymptomatic studies in ALS: rationale, challenges, and approach.

Authors:  Michael Benatar; Joanne Wuu
Journal:  Neurology       Date:  2012-10-16       Impact factor: 9.910

Review 3.  The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?

Authors:  Rangariroyashe H Chipika; We Fong Siah; Mary Clare McKenna; Stacey Li Hi Shing; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2020-10-31       Impact factor: 6.682

Review 4.  Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene.

Authors:  Peter M Andersen
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

Review 5.  Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.

Authors:  Robert Bowser; Martin R Turner; Jeremy Shefner
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

6.  Handgrip maximal voluntary isometric contraction does not correlate with thenar motor unit number estimation.

Authors:  Arun Aggarwal
Journal:  Neurol Res Int       Date:  2012-05-09

7.  Differential motor neuron impairment and axonal regeneration in sporadic and familiar amyotrophic lateral sclerosis with SOD-1 mutations: lessons from neurophysiology.

Authors:  Tommaso Bocci; Chiara Pecori; Elisa Giorli; Lucia Briscese; Silvia Tognazzi; Matteo Caleo; Ferdinando Sartucci
Journal:  Int J Mol Sci       Date:  2011-12-09       Impact factor: 5.923

Review 8.  Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?

Authors:  Ahmed Abdelhak; Andreas Junker; Johannes Brettschneider; Jan Kassubek; Albert C Ludolph; Markus Otto; Hayrettin Tumani
Journal:  Int J Mol Sci       Date:  2015-07-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.